for CVD-which include hypertension, smoking, abdominal obesity, abnormal lipids, diabetes 73 mellitus, stress, low consumption of fruits and vegetables, and lack of regular physical 74 activity-are the major contributors to CVD morbidity and mortality (Dahlöf 2010) . 75
Additionally, reduced plasma HDL levels and elevated plasma TAG concentrations are known 76 to be significant risk factors for ischemic heart disease (IHD) (Lewington, Whitlock et al. 2007 ; 77
Frikke-Schmidt, Nordestgaard et al. 2008). C-reactive protein (CRP) is another CVD risk 78
marker (Ridker, Danielson et al. 2009 ). In addition, high plasma levels of homocysteine are 79 considered to be a risk factor for vascular disease, heart failure and strokes (Kaptoge, Di 80 The health benefits of polyphenols provided by wine intake are of particular interest. In the 94 present study, a long-term feeding trial was performed to determine changes in urinary 95 metabolites between different metabotypes. Therefore, the aim of the present work was to 96 classify a specific population into phenotypic groups according to their biochemical 97 characteristics, and then to use 1 H-NMR-based urinary metabolomics to observe the different 98 metabolic responses after red wine polyphenols intake. 99
Angelantonio et al. 2010). Another important risk factor is type 2 diabetes mellitus (T2D)
.
MATERIAL AND METHODS

100
1 Subjects and Study Design 101
The study was a prospective, randomized, crossover, and controlled trial (Chiva-Blanch, Urpi-102 Sarda et al. 2012). High-risk subjects aged ≥55 years without documented CHD (CHD: 103 ischemic heart disease-angina/recent or past myocardial infarction/previous or cerebral 104 vascular accident, peripheral vascular disease) were recruited for the study. The subjects 105 included had diabetes mellitus or more than three of the following CHD risk factors: tobacco 106 smoking, hypertension, hypercholesterolemia, plasma LDL cholesterol ≥160 mg/dL, plasma 107 HDL cholesterol <40 mg/dL, obesity (BMI (in kg/m2) ≥30), and/or a family history of 108 premature CHD (first-line male relatives <55 years or females <65 years). Participants had to 109 voluntarily give signed informed consent. Subjects with a previous history of CVD, any severe 110 chronic disease, alcoholism, or other toxic substance abuse were excluded. 111
To fulfil the objectives of the present study, we used 1 H-NMR spectroscopy to evaluate the 112 urinary metabolomes from 57 participants between baseline and after 28 days of red wine 113 polyphenols intake (WPI, polyphenol content:733 Equivalents of Gallic Acid [EGA/day]) in 114 form of dealcoholized wine from a Merlot grape variety. Results of polyphenol composition 115 analysis of the beverages are shown in Supplemental material, Table S1 . The Institutional 116
Review Board of the hospital approved the study protocol, and all participants gave written 117 consent before participation in the study. The trial has been registered in the Current Controlled 118
Trials in London, International Standard Randomized Controlled Trial Number 119 (ISRCTN88720134). 120
Anthropometric Measurements and Biochemical Analyses 121
Anthropometric measurements and biochemical analyses were performed using standardized 122 methods (Estruch, Martínez-González et al. 2006). BMI and WHR were measured in all the 123 participants to evaluate their obesity status. Systolic and diastolic blood pressures as well as 124 heart rate were also measured. Clinical parameters were tested in the blood and urine of 125 participants at the beginning of the study (baseline) in order to characterize the biochemical 126 status of each participant. Blood glucose levels, total cholesterol, high-density lipoprotein 127 cholesterol (HDL), low-density lipoprotein cholesterol (LDL), LDL/HDL ratio, 128 triacylglycerides (TAG), 24h-diuresis, plasmatic creatine, uric acid, aminotransferases, 129 bilirubin, ferritin, C-reactive protein, albumin, enzymes (alkaline phosphatase, lactate 130 dehydrogenase), ions (Na + , K + ), as well as globulins, apolipoprotein levels, hemoglobin and red 131 blood cell count; with several coagulation parameters (prothrombin, thrombin, fibrinogen) were 132 measured. In total, 69 anthropometric and biochemical baseline parameters were evaluated. 133
These are shown in Table 1 . 134
Biochemical Biomarkers and Clinical Phenotype by a k-means Algorithm 135
The final data set contained 69 variables from 57 samples (of the initial set of 61 individuals, 4 136 were excluded because of incomplete data regarding clinical and anthropometric parameters). 137
Prior to k-means analysis all variables were typified. All cluster metrics were computed with 138 1000 different random initializations of the k-means algorithm in order to avoid local minima. A 139 maximum number of 100 iterations were allowed in the k-means calculations. All computations 140
were carried out using the R package for Statistical Computing v. 2.14.1. This included the 141 statistics package for the k-means algorithm and the clValid package for the cluster validation 142
analysis. Dunn analysis for internal coherence and FOM analysis for external homogeneity were 143 applied to the dataset employing Euclidean distances and a k-means clustering algorithm. Our 144 results suggest that a cluster solution consisting of 4 centers or groups (4 clusters) showed the 145 optimal properties of internal coherence and grouping stability (the detailed methodology and 146 the validation procedure are in the supplemental material). 147
4 Metabolomic NMR Spectroscopy 148
1 H-NMR sample preparation, data acquisition and processing 149
The protocols used for this work were based on previously published methodology (Vázquez-150 4.75 and 5.00 ppm was excluded from the data set to avoid spectral interference from residual 160 water. 161
Statistical Analysis 162
Biochemical biomarkers and phenotyping cluster differences 163
Clusters were performed using k-means cluster analysis as described previously. A 164
Kolmogorov-Smirnov test (p<0.05) was used to test the normality of the all variables using 165 SPSS, version 18.0 for Windows (SPSS ® , Chicago, IL, USA). ANOVA analysis was performed 166 to evaluate differences in the mean biochemical measurements across clusters where statistical 167 differences were analyzed (p<0.05). Comparisons between clusters were assessed using a 168
Tukey post-hoc multiple comparison test. In the case of non-parametric variables, a Kruskall 169
Wallis test was used to test significant differences. Additionally, a Mann-Whitney test was used 170 to detect significances between clusters. All these tests were performed by SPSS, version 18.0 171 for Windows (SPSS ® , Chicago, IL, USA). 172
Metabolomic cluster analysis-OSC-PLS-DA multivariate analysis 173
Data generated from the NMR spectral integration were submitted to MetaboAnalyst (Xia, 174 Mandal et al. 2012). Data were normalized using the sum of the spectral intensities, then log 175 transformed and Pareto scaled. Data were then analyzed using the SIMCA-P+ 13 software 176 (Umetrics, Umea, Sweden) by multivariate discriminant analysis OSC-PLS-DA. A pairwise 177 comparison analysis between the four clusters was carried out. The quality of the models was 178 evaluated by the goodness-of-fit parameter (R 2 X), the proportion of the variance of the response 179 variable that is explained by the model (R 2 Y) and the predictive ability parameter (Q), which 180 was calculated using seven-fold internal cross-validation (Vázquez-Fresno, . 181
Validation of the OSC-PLS-DA models was carried out by a permutation test (n=200). 182
Additional information about the methodology is provided in the supplementary data. After 183 untargeted analysis with baseline samples which characterized two most discriminant clusters, 184 then, the quantification of the samples was performed for these two clusters. 185
3 Metabolomic phenotype analysis by ANOVA 186
Quantified data were submitted to MetaboAnalyst in order to find possible differences between 187 clusters after WPI and normalized (24-h urine volume normalization, cube root transformed and 188
Pareto scaled) (Xia, Mandal et al. 2012 ) before further analysis. Metabolites were analyzed by a 189 one-way ANOVA test followed by Fisher's LSD test for multiple comparisons. The false 190 discovery rate (FDR) test, a statistical approach to the problem of multiple comparisons, was 191 used in this study to counter the effect of multiple testing and verify the most discriminating 192 metabolites (Benjamini and Hochberg 1995). Box-plots were used to show the statistical 193 differences between treatments with P values <0.05 being considered significant. Figure 1  194 displays a summary of the steps followed in this study. 195
Metabolite Identification and Quantification 196
The methyl singlet produced by a known quantity of TSP (0.97mM) was used as an internal 197 standard for chemical shift referencing (set to 0 ppm) and for quantification. The 1 H-NMR 198 spectra were analyzed using the Chenomx NMR Suite Professional Software package (version 199 7.8; Chenomx Inc, Edmonton, ALB, Canada), which permitted both identification and 200 quantification by manually fitting the NMR spectra to an internal metabolite database. 61 participants were initially recruited into this study; of these, 57 participants were included in 205 the final cluster analysis (4 were removed from the study because an incomplete biochemical 206 profile). Of the 69 baseline biochemical parameters, k-means cluster analysis classified 4 207 distinct phenotypic groups: cluster 1 (n= 12), cluster 2 (n= 13), cluster 3 (n= 14) and cluster 4 208 (n= 18). Age, smoking habits, mean dietary intake, mean concentrations of biochemical 209 parameters and statistical tests for each cluster are presented in Table 1 . Cluster 1 was defined 210 by a significantly lower systolic blood pressure (mmHg), α2-globulin (%) and neutrophil levels 211 (%); higher total cholesterol (mg/dL), LDL cholesterol (mg/dL), apolipoprotein B (mg/dL), and 212 apolipoprotein B/apolipoprotein A ratio (APOB/APOA), compared with all other clusters. 213
Cluster 2 showed lower LDL/HDL ratio compared with all other clusters and significantly 214 higher blood glucose levels compared to cluster 4. Cluster 3 was characterized by significantly 215
higher BMI values, α2-globulin (%), β-globulin (%),albumin/globulin ratio, and homocysteine 216 (µmol/L) levels and a lower albumin percentage (%) compared with the other clusters. In 217 addition, CRP values were the highest in cluster 3 and statistically significant compared with 218 clusters 1 and 4. Furthermore, glucose levels were significantly higher in cluster 3 (>126mg/dL) 219 compared with cluster 4 (<110mg/dL). More than >126mg/dL is diagnostic of T2D following 220 (Table 1) . 242
Clinical Phenotypes and NMR-based Metabolomic Profiles 243
After separation of the participants into 4 biochemically distinct clusters, an OSC-PLS-DA 244 analysis was performed to discriminate the clusters by their NMR-derived urinary profiles. The 245 results obtained by OSC-PLS-DA showed that the most strongly discriminated clusters were 246 cluster 3 versus cluster 4 (see Supplemental Material); for this reason, all subsequent analyses 247 were focused on further characterizing cluster 3 which was named the "obese and diabetic 248
cluster" (OD-c), versus cluster 4 or named the "healthier cluster" (H-c). 249 Table 2 After false discovery rate (FDR) correction, tartrate, glucose and 4-hydroxyphenylacetate (4-258 HPA) exhibited significant results. Different patterns of response were observed for these 3 259 metabolites: Tartrate was higher for both clusters after WPI (OD-c_WPI and H-c_WPI) (wine 260 polyphenols intervention metabolite). Glucose was higher in the baseline group and after 261 intervention in cluster OD-c (OD-c_BAS, OD-c_WPI) compared with cluster H-c (H-c_BAS 262 and H-c_WPI) (metabolic phenotype related metabolite) characteristic for cluster OD-c. Finally, 263 4-HPA showed higher urinary excretion after WPI among subjects H-c_WPI than those in OD-264 c_WPI and at baseline (OD-c_BAS, H-c_BAS), exhibiting a distinct post-intervention 265 metabolic response in individuals for different clusters (metabotypic intervention effect). Box-266 plots show the statistical differences observed for these metabolites by multiple comparison 267 ANOVA analysis (Figure 2) . 268
3 Metabolomic Phenotype Analysis to Responses to Wine Polyphenol Intake 250
Tartrate is the major organic acid in grapes and so it is also present in wine (Son, Kim et al. 
CONCLUSIONS
307
The present study has shown that phenotypic analysis using an unsupervised clustering 308 technique (k-means analysis) can identify clusters according with their biochemical profiles. 309
The two most discriminating clusters were named according to their clinical parameters and 310 identified as the "obese and diabetic cluster" (OD-c) and the "healthier cluster" (H-c). 311
Moreover, metabolomic phenotyping using NMR detected a distinct metabolic response 312 between individuals grouped in these phenotypic clusters. In particular, comparisons between 313 OD-c and H-c exhibited different levels of excretion of 4-HPA after wine polyphenols intake. 314
Likewise, a metabolite linked with a specific metabotype (glucose) and another metabolite 315 
Supported by the Spanish National Grants from Ministry of Economy and Competitiveness 323 (MINECO, TEC2013-44666-R) and cofounded by FEDER (Fondo Europeo de Desarrollo 324
Regional): AGL2009-13906-C02-01, CIberOBN, as well as PI13/01172 Project, (Plan N de I+D+i 325
2013-2016) by ISCII-Subdirección General de Evaluación y Fomento de la Investigación and the 326
JPI HDHL FOODBALL (PCIN-2014-133). We also thank the award of 2014SGR1566 from the 327
Generalitat de Catalunya's Agency AGAUR. R.V.-F, and R. Ll. would like to thank the FPI 328 fellowship and the "Ramon y Cajal" programmes of the Spanish Government and the Fondo Social 329
Europeo. CIBER-BBN is an initiative of the Spanish ISCIII. We thank the participants for their 330 collaboration in the study. 331
The authors have declared no conflict of interest. obese and diabetic cluster in basal period; H-c_BAS: healthier cluster in basal period; OD-500 c_WPI: obese and diabetic cluster after wine polyphenols intake; H-c_WPI: healthier cluster 501 after wine polyphenols intake. 502
